Response to: COVID-related upsurge in diagnoses of advanced breast cancer—is a disruption in mammography screening the one to be blamed?

por Toss, A.
Publicado 2021

Are you treating ypN0 patient with adjuvant abemaciclib?

por Toss, A., Moscetti, L.
Publicado 2023

NUT midline carcinoma of the head and neck: current perspectives

por Napolitano, M, Venturelli, M, Molinaro, E, Toss, A
Publicado 2019

COVID-related disruption in mammographic screening: a year later

por Toss, A., Callegari, V., Cortesi, G., Civallero, M., Armocida, C., Piacentini, F.
Publicado 2022

Quality of life of therapies for hormone receptor positive advanced/metastatic breast cancer: Regulatory aspects and clinical impact in Europe

por Moscetti, L., Sperduti, I., Frassoldati, A., Musolino, A., Nasso, C., Toss, A., Omarini, C., Dominici, M., Piacentini, F.
Publicado 2021

A phase II study of pembrolizumab plus carboplatin in BRCA-related metastatic breast cancer (PEMBRACA)

por Cortesi, L., Venturelli, M., Cortesi, G., Caggia, F., Toss, A., Barbieri, E., De Giorgi, U., Guarneri, V., Musolino, A., De Matteis, E., Zambelli, A., Bisagni, G., Dominici, M.
Publicado 2023

Cancer burden in adolescents and young adults in Europe

por Trama, A., Stark, D., Bozovic-Spasojevic, I., Gaspar, N., Peccatori, F., Toss, A., Bernasconi, A., Quarello, P., Scheinemann, K., Jezdic, S., Blondeel, A., Mountzios, G., Bielack, S., Saloustros, E., Ferrari, A.
Publicado 2023

Two-month stop in mammographic screening significantly impacts on breast cancer stage at diagnosis and upfront treatment in the COVID era

por Toss, A., Isca, C., Venturelli, M., Nasso, C., Ficarra, G., Bellelli, V., Armocida, C., Barbieri, E., Cortesi, L., Moscetti, L., Piacentini, F., Omarini, C., Andreotti, A., Gambini, A., Battista, R., Dominici, M., Tazzioli, G.
Publicado 2021